HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong Hwan Han Selected Research

Pyrogallol

1/2010The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
1/2009Pyrogallol inhibits the growth of lung cancer Calu-6 cells via caspase-dependent apoptosis.
1/2009Pyrogallol inhibits the growth of human pulmonary adenocarcinoma A549 cells by arresting cell cycle and triggering apoptosis.
11/2008Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion.
9/2008Pyrogallol inhibits the growth of human lung cancer Calu-6 cells via arresting the cell cycle arrest.
8/2008Pyrogallol inhibits the growth of gastric cancer SNU-484 cells via induction of apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong Hwan Han Research Topics

Disease

19Lung Neoplasms (Lung Cancer)
01/2019 - 08/2008
6Adenocarcinoma
01/2010 - 04/2008
3Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2010 - 07/2009
2Inflammation (Inflammations)
11/2020 - 01/2016
2Obesity
01/2016 - 06/2012
2Insulin Resistance
01/2016 - 06/2012
2Necrosis
05/2010 - 05/2010
1Neoplasms (Cancer)
11/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020
1Chronic Obstructive Pulmonary Disease (COPD)
11/2020
1Carcinogenesis
01/2019
1Hypertrophy
01/2016
1Body Weight (Weight, Body)
06/2015
1Stomach Neoplasms (Stomach Cancer)
08/2008

Drug/Important Bio-Agent (IBA)

15Glutathione (Reduced Glutathione)IBA
07/2010 - 11/2008
12Reactive Oxygen Species (Oxygen Radicals)IBA
07/2010 - 11/2008
6benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
07/2010 - 07/2009
6PyrogallolIBA
01/2010 - 08/2008
5Proteasome InhibitorsIBA
07/2010 - 01/2010
4Antimycin AIBA
01/2010 - 09/2008
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2010 - 01/2010
2Glucose (Dextrose)FDA LinkGeneric
01/2016 - 06/2012
2Insulin (Novolin)FDA Link
01/2016 - 06/2012
2AntioxidantsIBA
06/2012 - 04/2010
2Gallic AcidIBA
05/2010 - 05/2010
2Matrix Metalloproteinases (MMPs)IBA
05/2010 - 05/2010
2Buthionine SulfoximineIBA
04/2010 - 08/2008
2Caspase InhibitorsIBA
09/2009 - 11/2008
1SmokeIBA
11/2020
1phorbol-12-myristateIBA
11/2020
1CarcinogensIBA
11/2020
1Conditioned Culture MediaIBA
11/2020
1Immune Checkpoint ProteinsIBA
11/2020
1LipopolysaccharidesIBA
11/2020
14- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA
11/2020
1Hyaluronic Acid (Hyaluronan)IBA
01/2019
1LeptinIBA
01/2016
1Superoxide DismutaseIBA
01/2016
1Fatty Acids (Saturated Fatty Acids)IBA
01/2016
1LipidsIBA
06/2015
1Blood Glucose (Blood Sugar)IBA
06/2015
1Phosphotransferases (Kinase)IBA
06/2010
1MitogensIBA
06/2010
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2010
1Proteins (Proteins, Gene)FDA Link
06/2010
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
05/2010
1Mitogen-Activated Protein KinasesIBA
05/2010
1Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link
04/2010
1Cysteine (L-Cysteine)FDA Link
04/2010
1phenylhydrazoneIBA
11/2009
1Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone (FCCP)IBA
11/2009
1mesoxalonitrileIBA
11/2009
11,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltIBA
01/2009
1CaspasesIBA
11/2008
1Arsenic Trioxide (Trisenox)FDA Link
08/2008
12,4-Dinitrophenol (2,4 Dinitrophenol)IBA
04/2008

Therapy/Procedure

2Therapeutics
11/2020 - 01/2019